Hormesis in carcinogenicity of non-genotoxic carcinogens

Journal of Toxicologic Pathology

Volumn 19, Issue 3, 2006, Pages 111-122

  Kinoshita, Anna ^a   Wanibuchi, Hideki ^a   Wei, Min ^a   Fukushima, Shoji ^a,b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Japan Bioassay Research Center   (Japan)

Author keywords

Hormesis; Non genotoxic carcinogen; Oxidative stress; Threshold

Indexed keywords

EID: 33750020667     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.19.111     Document Type: Review

References (94)

1. Schoeny R. Use of genetic toxicology data in U.S. EPA risk assessment: the mercury study report as an example. Environ Health Perspect. 104 (Suppl 3): 663-673. 1996.
2. Hengstler JG, Bogdanffy MS, Bolt HM, and Oesch F. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu Rev Pharmacol Toxicol. 43: 485-520. 2003.
3. Lynch A, Harvey J, Aylott M, Nicholas E, Burman M, Siddiqui A, Walker S, and Rees R. Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis. 18: 345-353. 2003.
4. Decordier I, Dillen L, Cundari E, and Kirsch-Volders M. Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis. 17: 337-344. 2002.
5. Kirsch-Volders M, Vanhauwaert A, Eichenlaub-Ritter U, and Decordier I. Indirect mechanisms of genotoxicity. Toxicol Lett. 140-141: 63-74. 2003.
6. Thier R, Bonacker D, Stoiber T, Bohm KJ, Wang M, Unger E, Bolt HM, and Degen G. Interaction of metal salts with cytoskeletal motor protein systems. Toxicol Lett. 140-141: 75-81. 2003.
7. Bonacker D, Stoiber T, Bohm KJ, Unger E, Degen GH, Thier R, and Bolt HM. Chromosomal genotoxicity of nitrobenzene and benzonitrile. Arch Toxicol. 78: 49-57. 2004.
8. Bolt HM, Foth H, Hengstler JG, and Degen GH. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicol Lett. 151: 29-41. 2004.
9. Williams GM and Whysner J. Epigenetic carcinogens: evaluation and risk assessment. Exp Toxicol Pathol. 48: 189-195. 1996.
10. Bombail V, Moggs JG, and Orphanides G. Perturbation of epigenetic status by toxicants. Toxicol Lett. 149: 51-58. 2004.
11. Rozman KK. Rebuttal to Haseman. Threshold extrapolation in chemical carcinogenesis. Toxicol Pathol. 31: 714-716. 2003.
12. Renn O. Hormesis and risk communication. Hum Exp Toxicol. 22: 3-24. 2003.
13. Kitano M, Ichihara. T, Matsuda T, Wanibuchi H, Tamano S, Hagiwara A, Imaoka S, Funae Y, Shirai T, and Fukushima S. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis. 19: 1475-1480. 1998.
14. Kinoshita A, Wanibuchi H, Morimura K, Wei M, Shen J, Imaoka S, Funae Y, and Fukushima S. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis. 24: 1389-1399. 2003.
15. Masuda C, Wanibuchi H, Otori K, Wei M, Yamamoto S, Hiroi T, Imaoka S, Funae Y, and Fukushima S. Presence of a no-observed effect level for enhancing effects of development of the alpha-isomer of benzene hexachloride (alpha-BHC) on diethylnitrosamine-initiated hepatic foci in rats. Cancer Lett. 163: 179-185. 2001.
16. Sukata T, Uwagawa S, Ozaki K, Ogawa M, Nishikawa T, Iwai S, Kinoshita A, Wanibuchi H, Imaoka S, Funae Y, Okuno Y, and Fukushima S. Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2- trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int J Cancer. 99: 112-118. 2002.
17. Kitchin KT, Brown JL, and Setzer RW. Dose-response relationship in multistage carcinogenesis: promoters. Environ Health Perspect. 102 (Suppl 1): 255-264. 1994.
18. Williams GM, Iatropoulos MJ, and Jeffrey AM. Thresholds for the effects of 2-acetylaminofluorene in rat liver. Toxicol Pathol. 32 (Suppl 2): 85-91. 2004.
19. Williams GM and Iatropoulos MJ. Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol Pathol. 30: 41-53. 2002.
20. Pollycove M and Feinendegen LE. Biologic responses to low doses of ionizing radiation: Detriment versus hormesis. Part 2. Dose responses of organisms. J Nucl Med. 42: 26N-32N, 37N. 2001.
21. Calabrese EJ. Hormesis: changing view of the dose-response, a personal account of the history and current status. Mutat Res. 511: 181-189. 2002.
22. Stebbing AR. Hormesis: the stimulation of growth by low levels of inhibitors. Sci Total Environ. 22: 213-234. 1982.
23. Hunt DL and Bowman D. A parametric model for detecting hormetic effects in developmental toxicity studies. Risk Anal. 24: 65-72. 2004.
24. Parsons PA. Energy, stress and the invalid linear nothreshold premise: a generalization illustrated by ionizing radiation. Biogerontology. 4: 227-231. 2003.
25. Pollycove M and Feinendegen LE Radiation-induced versus endogenous DNA damage: possible effect of inducible protective responses in mitigating endogenous damage. Hum Exp Toxicol. 22: 290-306, discussion 307, 315-317, 319-323. 2003.
26. Ina Y and Sakai K. Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains: analysis of immune cell populations and surface molecules. Int J Radiat Biol. 81: 721-729. 2005.
27. Calabrese EJ and Baldwin LA. Can the concept of hormesis be generalized to carcinogenesis? Regul Toxicol Pharmacol. 28: 230-241. 1998.
28. Calabrese EJ. Hormesis: from marginalization to mainstream: A case for hormesis as the default dose-response model in risk assessment. Toxicol Appl Pharmacol. 197: 125-136. 2004.
29. Calabrese EJ. Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol. 35: 463-582. 2005.
30. Camurri L, Codeluppi S, Pedroni C, and Scarduelli L. Chromosomal aberrations and sister-chromatid exchanges in workers exposed to styrene. Mutat Res. 119: 361-369. 1983.
31. Kleczkowska HE and Althaus FR. Response of human keratinocytes to extremely low concentrations of N-methyl-N'-nitro-N-nitrosoguanidine. Mutat Res. 367: 151-159. 1996.
32. Liu Y, Egyhazi S, Hansson J, Bhide SV, Kulkami PS, and Grafstrom, RC. O6-methylguanine-DNA methyltransferase activity in human buccal mucosal tissue and cell cultures. Complex mixtures related to habitual use of tobacco and betel quid inhibit the activity in vitro. Carcinogenesis. 18: 1889-1895. 1997.
33. Kitchin KT and Brown JL. Dose-response relationship for rat liver DNA damage caused by 49 rodent carcinogens. Toxicology. 88: 31-49. 1994.
34. Office and Technology Assessment (OTA). Cancer Testing Technology and Saccharin. U.S. Government Printing Office, Washington, DC, 1977.
35. Young SS and Gries CL. Exploration of the negative correlation between proliferative hepatocellular lesions and lymphoma in rats and mice - establishment and implications. Fundam Appl Toxicol. 4: 632-640. 1984.
36. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, and Humiston CG. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 46: 279-303. 1978.
37. Cook RJ and Farewell VT. Guidelines for monitoring efficacy and toxicity responses in clinical trials. Biometrics. 50: 1146-1152. 1994.
38. Nordberg GF and Andersen O. Metal interactions in carcinogenesis: enhancement, inhibition. Environ Health Perspect. 40: 65-81. 1981.
39. Nesnow S, Ross JA, Nelson G, Wilson K, Roop BC, Jeffers AJ, Galati AJ, Stoner GD, Sangaiah R, Gold A. and Mass MJ. Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A/J mouse lung. Carcinogenesis. 15: 601-606. 1994.
40. O'Gara RW, Kelly MG, Brown J, and Mantel N. Induction of tumors in mice given a minute single dose of dibenz[a,h]anthracene or 3-methylcholanthrene as newborns. A dose-response study. J Natl Cancer Inst. 35: 1027-1042. 1965.
41. Prahalad AK, Ross JA, Nelson GB, Roop BC, King LC, Nesnow S, and Mass MJ. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis. 18: 1955-1963. 1997.
42. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, Wenk ML, Henneman JR, and Balaschak MS. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res. 48: 4656-4663. 1988.
43. Goldsworthy T, Campbell HA, and Pitot HC. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis. 5: 67-71. 1984.
44. Kitagawa T. Promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Toxicol Pathol. 14: 309-314. 1986.
45. Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glauert HP, Maronpot RR, and Campbell HA. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis. 8: 1491-1499. 1987.
46. Maekawa A, Onodera H, Ogasawara H, Matsushima Y, Mitsumori K, and Hayashi Y. Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine. Carcinogenesis. 13: 501-503. 1992.
47. Ito N, Tamano S, and Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94: 3-8. 2003.
48. Roos D and Winterbourn CC. Immunology. Lethal weapons. Science. 296: 669-671. 2002.
49. Whiteman M, Hong HS, Jenner A, and Halliwell B. Loss of oxidized and chlorinated bases in DNA treated with reactive oxygen species: implications for assessment of oxidative damage in vivo. Biochem Biophys Res Commun. 296: 883-889. 2002.
50. Ito N, Nagasaki H, Aoe H, Sugihara S, and Miyata Y. Development of hepatocellular carcinomas in rats treated with benzene hexachloride. J Natl Cancer Inst. 54: 801-805. 1975.
51. Ito N, Hananouchi M, Sugihara S, Shirai T, and Tsuda H. Reversibility and irreversibility of liver tumors in mice induced by the alpha isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res. 36: 2227-2234. 1976.
52. Koransky W, Portig J, Vohland HW, and Klempau I. Activation of microsome enzymes by hexachlorocyclohexane isomers. Its effect on Scilliroside poisoning in rats. Naunyn Schmiedebergs Arch Pharmacol. 247: 61-70. 1964.
53. Schlicht I, Koransky W, Magour S, and Schulte-Hermann R. Enlargement and DNA synthesis by the liver under in influence of substances alien to the body. Naunyn Schmiedebergs Arch Exp Pathol Pharmacol. 261: 26-41. 1968.
54. Schulte-Hermann R, Thom R, Schlicht I, and Koransky W. Number and "ploidy" of liver cell nuclei under the influence of substances alien to the body. Analysis by means of an electronic particle counter. Naunyn Schmiedebergs Arch Exp Pathol Pharmacol. 261: 42-58. 1968.
55. Butterworth BE. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat Res. 239: 117-132. 1990.
56. Butterworth BE and Goldsworthy TL. The role of cell proliferation in multistage carcinogenesis. Proc Soc Exp Biol Med. 198: 683-687. 1991.
57. Puatanachokchai R, Morimura K, Wanibuchi H, Oka M, Kinoshita A, Mitsuru F, Yamaguchi S, Funae Y, and Fukushima, S. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes. Cancer Lett. 240: 102-113. 2006.
58. Honkakoski P, Zelko I, Sueyoshi T, and Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol. 18: 5652-5658. 1998.
59. Gastel JA. Early indicators of response in biologically based risk assessment for nongenotoxic carcinogens. Regul Toxicol Pharmacol. 33: 393-398. 2001.
60. Kraus P, Gross B, and Kloft HD. The elevation of rat liver glutathione-S-transferase activity by alpha-hexachlorocyclohexane. Biochem Pharmacol. 30: 355-361. 1981.
61. Kushida M, Sukata T, Uwagawa S, Ozaki K, Kinoshita A, Wanibuchi H, Morimura K, Okuno Y, and Fukushima S. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms. Toxicol Appl Pharmacol. 208: 285-294. 2005.
62. Ito A, Takii T, Matsumura T, and Onozaki K. Augmentation of type I IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes. J Immunol. 162: 4260-4265. 1999.
63. Boulton R, Woodman A, Calnan D, Selden C, Tam F, and Hodgson H. Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology. 26: 49-58. 1997.
64. Ross HJ. The antiproliferative effect of trans-retinoic acid is associated with selective induction of interleukin-1 beta, a cytokine that directly inhibits growth of lung cancer cells. Oncol Res. 8: 171-178. 1996.
65. Wang Z, Wang M, and Carr BI. The inhibitory effect of interleukin 1beta on rat hepatocyte DNA synthesis is mediated by nitric oxide. Hepatology. 28: 430-435. 1998.
66. Conolly RB and Lutz WK. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. Toxicol Sci. 77: 151-157. 2004.
67. Plante I, Charbonneau M, and Cyr DG. Decreased gap junctional intercellular communication in hexachlorobenzene-induced gender-specific hepatic tumor formation in the rat. Carcinogenesis. 23: 1243-1249. 2002.
68. Mally A and Chipman JK. Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat. Toxicology. 180: 233-248. 2002.
69. Chipman JK, Mally A, and Edwards GO. Disruption of gap junctions in toxicity and carcinogenicity. Toxicol Sci. 71: 146-153. 2003.
70. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, and Walborg EF, Jr. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 106 (Suppl 1): 289-295. 1998.
71. Piechocki MP, Toti RM, Fernstrom MJ, Burk RD, and Ruch RJ. Liver cell-specific transcriptional regulation of connexin32. Biochim Biophys Acta. 1491: 107-122. 2000.
72. Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, and Ruch RJ. Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1alpha. Arch Biochem Biophys. 407: 160-167. 2002.
73. Camargo CA, Jr, Stampfer MJ, Glynn RJ, Gaziano JM, Manson JE, Goldhaber SZ, and Hennekens CH. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation. 95: 577-580. 1997.
74. Berger K, Ajani UA, Kase CS, Gaziano JM, Buring JE, Glynn RJ, and Hennekens CH. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med. 341: 1557-1564. 1999.
75. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens CH, and Buring JE. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 35: 96-105. 2000.
76. Tsugane S, Fahey MT, Sasaki S, and Baba S. Alcohol consumption and all-cause and cancer mortality among middle-aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. Am J Epidemiol. 150: 1201-1207. 1999.
77. Calabrese EJ and Baldwin LA. Ethanol and hormesis. Crit Rev Toxicol. 33: 407-424. 2003.
78. Kikuchi S, Nakajima. T, Kobayashi O, Yamazaki T, Kikuichi M, Mori K, Oura S, Watanabe H, Nagawa H, Otani R, Okamoto N, Kurosawa M, Anzai H, Konishi T, Futagawa S, Mizobuchi N, Kobori O, Kaise R, Inaba Y, and Wada O. U-shaped effect of drinking and linear effect of smoking on risk for stomach cancer in Japan. Jpn J Cancer Res. 93: 953-959. 2002.
79. Kushida M, Wanibuchi H, Morimura K, Kinoshita A, Kang JS, Puatanachokchai R, Wei M, Funae Y, and Fukushima S. Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: evidence for a threshold. Cancer Sci. 96: 747-757. 2005.
80. Bartsch H and Nair J. Ultrasensitive and specific detection methods for exocylic DNA adducts: markers for lipid peroxidation and oxidative stress. Toxicology. 153: 105-114. 2000.
81. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 21: 361-370. 2000.
82. Nair J, Barbin A, Guichard Y, and Bartsch H. 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabeling. Carcinogenesis. 16: 613-617. 1995.
83. Hang B, Chenna A, Sagi J, and Singer B. Differential cleavage of oligonucleotides containing the benzene-derived adduct, 1,N6-benzetheno-dA, by the major human AP endonuclease HAP1 and Escherichia coli exonuclease III and endonuclease IV. Carcinogenesis. 19: 1339-1343. 1998.
84. Anisimov VN. Ageing and the mechanisms of carcinogenesis: some practical implications. J Exp Clin Cancer Res. 17: 263-268. 1998.
85. Goldberg Z and Lehnert BE. Radiation-induced effects in unirradiated cells: a review and implications in cancer. Int J Oncol. 21: 337-349. 2002.
86. Trosko JE, Chang CC, Upham BL, and Tai MH. Low-dose ionizing radiation: induction of differential intracellular signalling possibly affecting intercellular communication. Radiat Environ Biophys. 44: 3-9. 2005.
87. Little JB. Radiation carcinogenesis. Carcinogenesis. 21: 397-404. 2000.
88. Mesnil M, Piccoli C, and Yamasaki H. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res. 57: 2929-2932. 1997.
89. Mothersill C and Seymour C. Radiation-induced bystander effects, carcinogenesis and models. Oncogene. 22: 7028-7033. 2003.
90. Shao C, Furusawa Y, Aoki M, and Ando K. Role of gap junctional intercellular communication in radiation-induced bystander effects in human fibroblasts. Radiat Res. 160: 318-323. 2003.
91. Shao C, Furusawa Y, Kobayashi Y, Funayama T, and Wada S. Bystander effect induced by counted high-LET particles in confluent human fibroblasts: a mechanistic study. Faseb J. 17: 1422-1427. 2003.
92. Snyder AR. Review of radiation-induced bystander effects. Hum Exp Toxicol. 23: 87-89. 2004.
93. Biju MP, Pyroja S, Rajeshkumar NV, and Paulose CS. Enhanced GABA(B) receptor in neoplastic rat liver: induction of DNA synthesis by baclofen in hepatocyte cultures. J Biochem Mol Biol Biophys. 6: 209-214. 2002.
94. Erlitzki R, Gong Y, Zhang M, and Minuk G. Identification of gamma-aminobutyric acid receptor subunit types in human and rat liver. Am J Physiol Gastrointest Liver Physiol. 279: G733-739. 2000.